SHK

S H Kelkar & Company Share Price

₹252.45 -7.55 (-2.9%)

22 Dec, 2024 21:29

SIP TrendupStart SIP in SHK

Start SIP

Performance

  • Low
  • ₹252
  • High
  • ₹261
  • 52 Week Low
  • ₹138
  • 52 Week High
  • ₹336
  • Open Price₹260
  • Previous Close₹260
  • Volume269,376

Investment Returns

  • Over 1 Month -4.57%
  • Over 3 Month -0.9%
  • Over 6 Month + 21.57%
  • Over 1 Year + 73.68%
SIP Lightning

Smart Investing Starts Here Start SIP with S H Kelkar & Company for Steady Growth!

Invest Now

S H Kelkar & Company Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 183.2
  • PEG Ratio
  • -2.5
  • Market Cap Cr
  • 3,494
  • P/B Ratio
  • 2.9
  • Average True Range
  • 10.38
  • EPS
  • 8.99
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -4.44
  • RSI
  • 30.66
  • MFI
  • 38.97

S H Kelkar & Company Financials

S H Kelkar & Company Technicals

EMA & SMA

Current Price
₹252.45
-7.55 (-2.9%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹273.86
  • 50 Day
  • ₹277.91
  • 100 Day
  • ₹265.91
  • 200 Day
  • ₹239.96

Resistance and Support

254.97 Pivot Speed
  • R3 267.88
  • R2 264.42
  • R1 258.43
  • S1 248.98
  • S2 245.52
  • S3 239.53

What's your outlook on S H Kelkar & Company?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

S H Kelkar & Company Ltd. is a leading Indian manufacturer of fragrances and flavoring agents. The company specializes in developing innovative fragrance solutions for personal care, home care, and food industries, focusing on quality and customer satisfaction.

S H Kelkar & Co has an operating revenue of Rs. 2,041.87 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 9% is okay, ROE of 10% is good. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 11% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 136 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

S H Kelkar & Company Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-13 Quarterly Results
2024-05-27 Audited Results
2024-03-29 Interim Dividend
2024-02-07 Quarterly Results
Date Purpose Remarks
2024-04-12 INTERIM Rs.0.75 per share(7.5%)Interim Dividend

S H Kelkar & Company F&O

S H Kelkar & Company Shareholding Pattern

55.63%
1.86%
9.4%
0%
17.67%
15.44%

About S H Kelkar & Company

  • NSE Symbol
  • SHK
  • BSE Symbol
  • 539450
  • ISIN
  • INE500L01026

Similar Stocks to S H Kelkar & Company

S H Kelkar & Company FAQs

S H Kelkar & Company share price is ₹252 As on 22 December, 2024 | 21:15

The Market Cap of S H Kelkar & Company is ₹3494.4 Cr As on 22 December, 2024 | 21:15

The P/E ratio of S H Kelkar & Company is 183.2 As on 22 December, 2024 | 21:15

The PB ratio of S H Kelkar & Company is 2.9 As on 22 December, 2024 | 21:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23